Princeton Alpha Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-4,870
| Closed | -$310K | – | 790 |
|
2016
Q3 | $310K | Buy |
+4,870
| New | +$310K | 0.06% | 486 |
|
2015
Q3 | – | Sell |
-3,350
| Closed | -$211K | – | 825 |
|
2015
Q2 | $211K | Buy |
+3,350
| New | +$211K | 0.04% | 581 |
|
2014
Q4 | – | Sell |
-8,530
| Closed | -$250K | – | 766 |
|
2014
Q3 | $250K | Buy |
8,530
+1,892
| +29% | +$55.5K | 0.06% | 493 |
|
2014
Q2 | $258K | Buy |
+6,638
| New | +$258K | 0.05% | 495 |
|